Dareon-Lung-1 will test obrixtamig plus Tecentriq and chemo in small-cell lung cancer.
ApexOnco Front Page
Recent articles
The Sentry trial hits on spleen volume reduction, but misses on symptoms.
The upcoming Rasolute-304 trial will compare daraxonrasib versus observation.
But the group still hopes to get IGV-001 approved based on overall survival data.
A more comprehensive dataset on JANX007 sends the group’s stock down.
Car-T therapies and ADCs feature among recent first-in-human study entrants.
The agency approved eight oncology products over the month.
The pivotal Harmoni-GI3 study has started enrolling patients.
